New Drug Trial Offers Hope for Blood Cancer Patients

Adele Adams, a 59-year-old blood cancer patient, shares her positive experience with a new drug trial at The Christie Hospital in Manchester. The drug, NX-5948, shows potential in treating difficult-to-treat B-cell lymphomas, offering hope for patients who have exhausted traditional chemotherapy options. Dr. Kim Linton cautiously expresses optimism about the trial, highlighting the potential breakthrough in the fight against lymphoma.